Altimmune, Inc.
ALT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$95,059 | -$88,447 | -$84,713 | -$97,090 |
| Dep. & Amort. | $238 | $477 | $493 | $551 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $14,393 | $10,640 | $8,101 | $5,519 |
| Change in WC | $4,478 | -$8,274 | $14,111 | -$251 |
| Other Non-Cash | -$3,898 | $9,794 | -$578 | $13,033 |
| Operating Cash Flow | -$79,848 | -$75,810 | -$62,586 | -$78,238 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$47 | -$126 | -$12,117 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$115,731 | -$88,631 | -$73,273 | -$7,592 |
| Inv. Sales/Matur. | $87,345 | $102,410 | $0 | $107,427 |
| Other Inv. Act. | $0 | $0 | $0 | -$195 |
| Investing Cash Flow | -$28,386 | $13,732 | -$73,399 | $87,523 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $9,994 | $86,601 | $56,347 | $65,040 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $50 | -$496 | $434 | $58 |
| Financing Cash Flow | $10,044 | $86,105 | $56,781 | $65,098 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$98,190 | $24,027 | -$79,204 | $74,383 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $135,158 | $111,131 | $190,335 | $115,952 |
| End Cash | $36,968 | $135,158 | $111,131 | $190,335 |
| Free Cash Flow | -$79,848 | -$75,857 | -$62,712 | -$90,550 |